Page last updated: 2024-08-21

pyrazines and Adenomatosis, Familial Endocrine

pyrazines has been researched along with Adenomatosis, Familial Endocrine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Graw, J; Lee, M; Pellegata, NS; Roncaroli, F; Theodoropoulou, M; Zatelli, MC	1

Other Studies

1 other study(ies) available for pyrazines and Adenomatosis, Familial Endocrine

Article	Year
Levels of p27 sensitize to dual PI3K/mTOR inhibition. Molecular cancer therapeutics, 2011, Volume: 10, Issue:8 Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Line; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Disease Models, Animal; Drug Synergism; Gene Expression Regulation, Neoplastic; Mice; Multiple Endocrine Neoplasia; Phosphoinositide-3 Kinase Inhibitors; Pituitary Neoplasms; Proteasome Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazines; Rats; Signal Transduction; TOR Serine-Threonine Kinases	2011

Article

Year

Levels of p27 sensitize to dual PI3K/mTOR inhibition.

Molecular cancer therapeutics, 2011, Volume: 10, Issue:8

Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Line; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Disease Models, Animal; Drug Synergism; Gene Expression Regulation, Neoplastic; Mice; Multiple Endocrine Neoplasia; Phosphoinositide-3 Kinase Inhibitors; Pituitary Neoplasms; Proteasome Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazines; Rats; Signal Transduction; TOR Serine-Threonine Kinases

2011